LIVEONE, INC. (LVO)
LiveOne (Nasdaq: LVO) Doubles Down on Partnership with Tesla and AI Marketing to Increase ARPUs and Convert 1.1M+ Free Subscribers into Paid Users
LiveOne (Nasdaq: LVO) Doubles Down on Partnership with Tesla and AI Marketing to Increase ARPUs and Convert 1.1M+ Free Subscribers into Paid Users
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer
Columbus McKinnon to Present at Upcoming Wells Fargo Industrials & Materials Conference
Blue Gold Appoints Capital Markets Veteran as Chief Financial Officer
XTEND Selected for Phase II Qualifier of U.S. Department of Defense $1 Billion Drone Dominance Program
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial
HUHUTECH International Group Awarded Follow-On Contract from Anchor Customer to Support Continued Capacity Expansion in the Arizona Semiconductor Corridor
RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer
Promethean showcases award-winning workplace solutions at InfoComm 2026